期刊文献+

胰高血糖素样肽-1对缺氧/复氧诱导的乳鼠心肌细胞损伤的影响 被引量:2

Effects of glucagon-like peptide-1 on injury of neonatal mice cardiomyocytes induced by hypoxia-reoxygenation
下载PDF
导出
摘要 目的:研究胰高血糖素样肽-1(glucagon-like peptide-1,GLP-1)对缺氧/复氧(H/R)诱导的乳鼠心肌细胞损伤的影响及其可能的机制。方法:将体外培养乳鼠心肌细胞分为3组,即正常对照组、H/R组和GLP-1+H/R组。H/R损伤后,分别通过比色法、流式细胞术、荧光检测法测定上清液中乳酸脱氢酶(LDH)的活性、心肌细胞的凋亡率及半胱氨酸天冬氨酸特异性蛋白酶-3(caspase-3)的活性。结果:与正常对照组比较,H/R组LDH的活性、心肌细胞的凋亡率及caspase-3的活性均明显增高(P<0.01);而与H/R组相比,GLP-1+H/R组LDH的活性、心肌细胞的凋亡率及caspase-3的活性则明显降低(P<0.01)。结论:GLP-1可直接作用于心肌细胞,对H/R诱导的心肌细胞损伤产生一定的拮抗作用,其作用机制可能主要是通过抑制心肌细胞的凋亡所致;而GLP-1对心肌细胞凋亡的抑制作用,可能与其对caspase-3相关的凋亡或抗凋亡途径的调节有关。 AIM : To study the effects of glucagon-like peptide-1 ( GLP-1 ) on the injury of neonatal mice cardiomyocytes induced by hypoxia-reoxygenation (H/R) and to explore the possible mechanism. METHODS: Cultured neonatal mice cardiomyocytes were randomly divided into three groups: normal control group, H/R group, and H/R and GLP-1 group. LDH activity, apoptosis rate of cardiomyocytes and caspase-3 activity were detected. RESULTS: Compared with the normal control group, LDH activity, cardiomyocyte apoptosis rate and caspase-3 activity all increased significantly in the H/R group. Compared with the H/R group, the above three indexes all decreased in the I-I/R and GLP-1 groups. CONCLUSION: GLP-1 directly acts on cardiomyocytes and protects them from H/R injury mainly by inhibiting apoptosis. GLP-1 may exert its apoptotic effects through regulation of apoptotic or antiapoptotic pathways of caspase-3.
出处 《心脏杂志》 CAS 2010年第3期344-346,353,共4页 Chinese Heart Journal
  • 相关文献

参考文献9

  • 1Bullock BP, Heller RS, Habener JF, et al. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor[J]. Endocrinology, 1996, 137(7):2968-2978. 被引量:1
  • 2Wei Y, Mojsov S. Distribution of GLP-I and PACAP receptors in human tissue[J]. Acta Physiol Scand, 1996, 157(3) :355 -357. 被引量:1
  • 3Zhao T, Parikh P, Bhashyam S, et al. The direct effects of glucagon-like peptide-1 ( GLP-I ) on myocardial contractility and glucose uptake in normal and postischemie isolated rat hearts [ J ]. Pharmacol Exp Ther , 2006, 317(3):1106- 1113. 被引量:1
  • 4Kavianipour M, Ehlers MR, Malmberg K, et al. Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium[ J]. Peptides, 2003, 24 (4) :569 - 578. 被引量:1
  • 5Sonne DP, Engstrφm T, Treiman M. Protective effects of GLP-I analogues exendin-4 and GLP-1 (9-36) amide against ischemia-reperfu- sion injury in rat heart[J]. Regul Pept, 2008, 146(1 -3) :243 -249. 被引量:1
  • 6杨胜利,何作云,冯兵,王慧春,肖颖彬,张华.缺氧/复氧诱导培养人肥大心肌细胞凋亡模型的建立[J].重庆医学,2004,33(1):4-6. 被引量:15
  • 7马天舒,葛迎春,刘平,贾玉红,任慧君,徐亚娟,徐东铭.四逆汤类方提取物对乳鼠心肌细胞缺氧复氧损伤的保护作用[J].中国实验方剂学杂志,2005,11(4):48-51. 被引量:5
  • 8Farilla L, Hui H, Bertolotto C, et al. Glucagon-like peptide-I promotes islet cell growth and inhibits apoptosis in Zuker diabetic rats [ J ]. Endocrinology, 2002, 143 ( 11 ) :4397 - 4408. 被引量:1
  • 9Nikolaidis LA, Mankad S, Sokos GG, et al. Effects of glucagon-like peptide-I in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion [ J ]. Circulation, 2004, 109(8) :962 -965. 被引量:1

二级参考文献11

共引文献17

同被引文献12

  • 1周永淑,陈晓红.一个应引起广泛关注的综合征——代谢综合征[J].临床误诊误治,2006,19(11):1-3. 被引量:3
  • 2Grundy SM.Metabolic syndrome pandemic.Arteriosclerosis,thrombosis,and vascular biology 2008;28(4):629-636. 被引量:1
  • 3Saleem U,Khaleghi M,Morgenthaler NG,et al.Plasma carboxy-terminal provasopressin(copeptin):a novel marker of insulin resistance and metabolic syndrome.The Journal of clinical endocrinol- ogy and metabolism 2009;94(7):2558-2564. 被引量:1
  • 4Kwon G,Pappan KL,Marshall CA,et al.cAMP Dose-de- pendently prevents palmitate-induced apoptosis by both protein kinase A-and cAMP-uanine nucleotide exchange factor-dependent pathways in beta-cells.J Biol-Chem 2004;279(10):8938-8945. 被引量:1
  • 5Holst JJ:The physiology of glucagon-like peptide I.Physio- logical reviews 2007;87(4):1409-1439. 被引量:1
  • 6Grieve DJ,Cassidy RS,Green BD:Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-I:potential ther- apeutic benefits beyond glycaemic control British journal of pharmacol- ogy 2009;157(8):1340-1351. 被引量:1
  • 7Klonoff DC,,Buse JB,Nielsen LL,et al.Exenatide effects on diabetes,obesity,cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.CurrentMedical Research and Opinion 2008;10(24):275-286. 被引量:1
  • 8Food and Drug Administration Information for Heathcare Pro- fessionals Exenatide(marketed as Byetta).Available at Accessed Janu- ary 17,2008. 被引量:1
  • 9XIE Yun,WANG Shao-xin,SHA Wei-wei,ZHOU Xue,WANG Wei-tin,HAN Li-pin,LI Dai-qing,YU De-min.Effects and mechanism of glucagon-like peptide-1 on injury of rats cardiomyocytes induced by hypoxia-reoxygenation[J].Chinese Medical Journal,2008(21):2134-2138. 被引量:24
  • 10肖竹,田浩明,程中.胃肠激素与2型糖尿病发病机制的关系[J].西部医学,2009,21(10):1800-1803. 被引量:5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部